Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Adapting a Skills-Based Smoking Cessation Program for Gender-Diverse Adults Under Stress

Official title: Adapting and Pilot Testing a Skills-based Smoking Cessation Intervention to Address Developmental and Health-related Stress Among Adults Who Smoke

Run by Massachusetts General Hospital · NCT06654414 · Data updated 2026-11-12

A skills-based smoking cessation program is being adapted and tested to see if it helps gender-diverse adults who smoke, especially when stressed by gender-related factors and mood problems.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations3 sites (Boston, Massachusetts and 2 other locations)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedMarch 31, 2027
Study endsAugust 31, 2027
Registry record updatedOctober 8, 2026
Trial IDNCT06654414 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who identify as transgender or gender diverse, currently using combustible cigarettes or nicotine-containing e-cigarettes with smoking desire to quit, and English-speaking.

Probably not a fit

People without gender minority stress exposure or those not seeking to quit smoking may not benefit from this specific adaptation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project modifies an existing smoking cessation intervention to address gender minority stress and related anxiety and depression in adults who smoke. It will adapt the program PRIDE QUIT and compare it with enhanced treatment as usual in a pilot feasibility study. The study will recruit adults who identify as transgender or gender diverse, who use cigarettes or nicotine-containing products, and who want to quit, and will assess acceptability, usability, and preliminary outcomes. Feasibility metrics will include recruitment, retention, adherence, and participant feedback, along with preliminary signals of cessation success and mood changes. The work is led by Mass General Hospital with NCI collaboration and sites in Boston, MA.

Why it matters

Potential benefit: If successful, the adapted program could improve quit rates and reduce anxiety and depression for gender-diverse individuals who smoke.

How similar studies have gone: Similar targeted adaptations in tobacco care have shown promise in addressing minority stress, though this exact approach for gender-diverse individuals is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. aged 18+
2. self-reported difference between sex assigned at birth and gender identity
3. current use of combustible cigarettes (defined as self-reported 5 combustible cigarettes per day in any week in the past month and a carbon monoxide \[CO\] expired-air reading of ≥8ppm) OR current use of nicotine-containing e-cigarettes (defined by saliva cotinine level of ≥30ng/mL) with use of combustible cigarettes (5 cigarettes per day in any week in the past month)
4. desire to stop using tobacco products (defined by ≥5 on the Motivational Aspects of Smoking Cessation Questionnaire)
5. English-speaking.

Exclusion Criteria:

1. unable to provide informed consent
2. current interfering untreated or unstable major health condition (e.g., bipolar, current psychosis)
3. current use of psychotherapy for smoking cessation
4. participation in Aim 1a procedures.

Where it's running

  • Fenway Health
    Boston, Massachusetts, United States
    Recruiting
  • Massachusetts General Hopsital
    Boston, Massachusetts, United States
    Active not recruiting
  • Boston University - Charles River Campus
    Boston, Massachusetts, United States
    Active not recruiting

Study contacts

  • Principal investigator: Conall M O'Cleirigh, PhD — Massachusetts General Hospital, Behavioral Medicine Program
  • Study coordinator: Conall M O'Cleirigh, PhD
  • Email: cocleirigh@mgh.harvard.edu
  • Phone: 617-643-0385

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.